167 related articles for article (PubMed ID: 37769303)
1. Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
George JS; Naert MN; Lanes A; Yin S; Bharadwa S; Ginsburg ES; Srouji SS
Obstet Gynecol; 2023 Nov; 142(5):1019-1027. PubMed ID: 37769303
[TBL] [Abstract][Full Text] [Related]
2. Restoring Fertility of Patients with Severe Asherman's Syndrome in the Office Setting: A Step-by-Step Recipe for Success.
Di Spiezio-Sardo A; De Angelis MC; Dimitrios K; Manzi A; Zizolfi B; Carugno J; Isaacson K
J Minim Invasive Gynecol; 2023 May; 30(5):355-356. PubMed ID: 36764649
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopy for retained products of conception: a single-institution experience.
Han L; Shi G; Zheng A; Ruan J
BMC Womens Health; 2023 Jan; 23(1):25. PubMed ID: 36653813
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
Moore O; Tzur T; Vaknin Z; Rabbi ML; Smorgick N
Arch Gynecol Obstet; 2024 Jan; 309(1):205-210. PubMed ID: 37782418
[TBL] [Abstract][Full Text] [Related]
5. Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility.
Capmas P; Lobersztajn A; Duminil L; Barral T; Pourcelot AG; Fernandez H
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):151-154. PubMed ID: 30553048
[TBL] [Abstract][Full Text] [Related]
6. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for early pregnancy loss in women with first pregnancy undergoing in vitro fertilization-embryo transfer.
Wang M; Yang X; Li L; Zhu H; Zhang H; Jiang Y; Liu R
BMC Pregnancy Childbirth; 2022 Jul; 22(1):575. PubMed ID: 35854214
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
Bosteels J; van Wessel S; Weyers S; Broekmans FJ; D'Hooghe TM; Bongers MY; Mol BWJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009461. PubMed ID: 30521679
[TBL] [Abstract][Full Text] [Related]
9. Increased Fetal Chromosome Detection with the Use of Operative Hysteroscopy During Evacuation of Products of Conception for Diagnosed Miscarriage.
Cholkeri-Singh A; Zamfirova I; Miller CE
J Minim Invasive Gynecol; 2020 Jan; 27(1):160-165. PubMed ID: 30926368
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
11. 1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings.
Hinckley MD; Milki AA
JSLS; 2004; 8(2):103-7. PubMed ID: 15119651
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine Adhesions Following Miscarriage: Look and Learn.
Gilman AR; Dewar KM; Rhone SA; Fluker MR
J Obstet Gynaecol Can; 2016 May; 38(5):453-7. PubMed ID: 27261221
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment for early pregnancy loss following in vitro fertilization compared to spontaneous pregnancies.
Gluck O; Barber E; Friedman M; Feldstein O; Tal O; Grinstein E; Kerner R; Menasherof M; Saidian M; Weiner E; Sagiv R
Arch Gynecol Obstet; 2024 May; 309(5):2137-2141. PubMed ID: 38478159
[TBL] [Abstract][Full Text] [Related]
14. Early pregnancy loss in patients with polycystic ovary syndrome after IVM versus standard ovarian stimulation for IVF/ICSI.
Mackens S; Mostinckx L; Drakopoulos P; Segers I; Santos-Ribeiro S; Popovic-Todorovic B; Tournaye H; Blockeel C; De Vos M
Hum Reprod; 2020 Dec; 35(12):2763-2773. PubMed ID: 33025015
[TBL] [Abstract][Full Text] [Related]
15. Optimal Interval of Time from Operative Hysteroscopy to Embryo Transfer in an In Vitro Fertilization Cycle.
Aharon D; Sekhon L; Lee JA; Ascher-Walsh C; Copperman AB
J Minim Invasive Gynecol; 2019; 26(6):1083-1087.e1. PubMed ID: 30389583
[TBL] [Abstract][Full Text] [Related]
16. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
17. Reproductive and obstetric outcomes following operative hysteroscopy for treatment of retained products of conception.
Chill HH; Safrai M; Karavani G; Cohen A; Alexandroni H; Bahar R; Shushan A
Minerva Obstet Gynecol; 2021 Aug; 73(4):494-499. PubMed ID: 34319060
[TBL] [Abstract][Full Text] [Related]
18. Office hysteroscopy before first in vitro fertilization. A randomized controlled trial.
Ben Abid H; Fekih M; Fathallah K; Chachia S; Bibi M; Khairi H
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102109. PubMed ID: 33727208
[TBL] [Abstract][Full Text] [Related]
19. Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study.
Tzur Y; Berkovitz-Shperling R; Goitein Inbar T; Bar-On S; Gil Y; Levin I; Cohen A
Am J Obstet Gynecol; 2022 Oct; 227(4):599.e1-599.e9. PubMed ID: 35752301
[TBL] [Abstract][Full Text] [Related]
20. Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
Chen TX
Obstet Gynecol; 2024 Apr; 143(4):e129. PubMed ID: 38513247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
